Harrow Health Stock Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harrow health stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harrow Health Stock Down Today - Breaking & Trending Today

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […] ....

Craig Hallum , Institutional Trading Of Harrow Health , Eton Pharmaceuticals Inc , Harrow Health , Envestnet Asset Management Inc , Surface Ophthalmics Inc , Securities Exchange Commission , Wasatch Advisors Inc , Opaleye Management Inc , Harrow Health Inc , Prelude Capital Management , Pharmaceuticals Inc , Quarter For Harrow Health , Harrow Health Stock Down , News Ratings For Harrow Health Daily , Blackrock Inc , Get Free Report , Opaleye Management , Exchange Commission , Health Stock Down , Asset Management , Capital Management , State Street Corp , Street Corp , Surface Ophthalmics , Melt Pharmaceuticals ,

Short Interest in Harrow Health, Inc. (NASDAQ:HROW) Declines By 20.0%

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 4,890,000 shares, a decline of 20.0% from the November 15th total of 6,110,000 shares. Based on an average daily trading volume, of 682,900 shares, the days-to-cover […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Markl Baum , Harrow Health Inc , Eton Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Opaleye Management Inc , Pharmaceuticals Inc , Allspring Global Investments Holdings , Harrow Health Stock Down , Northwestern Mutual Wealth Management Co , Securities Exchange Commission , Harrow Health , Insider Activity At Harrow Health , Surface Ophthalmics Inc , Ameritas Investment Partners Inc , Life Insurance Co , Get Free Report , Opaleye Management , Exchange Commission , Kantonalbank Zurich Cantonalbank , Global Investments Holdings , Mutual Wealth Management , Ameritas Investment Partners , Health Stock Down , Surface Ophthalmics , Melt Pharmaceuticals ,

Harrow Health, Inc. (NASDAQ:HROW) Position Trimmed by Invictus Private Wealth LLC

Invictus Private Wealth LLC lowered its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 17.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 639,316 shares of the company’s stock after selling 134,806 shares during the period. Harrow Health makes up about 1.6% […] ....

Markl Baum , Martina Makary , Zurcher Kantonalbank Zurich Cantonalbank , Securities Exchange Commission , Quarter For Harrow Health , News Ratings For Harrow Health Daily , Pharmaceuticals Inc , Marshall Wace , Eton Pharmaceuticals Inc , Mendota Financial Group , Harrow Health , Insider Transactions At Harrow Health , Surface Ophthalmics Inc , Invictus Private Wealth , Harrow Health Stock Down , Jump Financial , Harrow Health Company Profile , Harrow Health Inc , Free Report , Private Wealth , Financial Group , Director Martin , Exchange Commission , Health Stock Down , Get Free Report , Surface Ophthalmics ,

Q2 2023 EPS Estimates for Harrow Health, Inc. Raised by B. Riley (NASDAQ:HROW)

Q2 2023 EPS Estimates for Harrow Health, Inc. Raised by B. Riley (NASDAQ:HROW)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Zurcher Kantonalbank Zurich Cantonalbank , Dorsey Wright Associates , Surface Ophthalmics Inc , Harrow Health , Harrow Health Company Profile , Tower Research Capital , Harrow Health Inc , Northwestern Mutual Wealth Management Co , Institutional Investors Weigh In On Harrow Health , Pharmaceuticals Inc , Harrow Health Stock Down , Eton Pharmaceuticals Inc , News Ratings For Harrow Health Daily , Free Report , Lake Street Capital , Health Stock Down , Get Free Report , Kantonalbank Zurich Cantonalbank , Mutual Wealth Management , Research Capital , Dark Forest Capital Management , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,

Harrow Health, Inc. (NASDAQ:HROW) Sees Significant Growth in Short Interest

Harrow Health, Inc. (NASDAQ:HROW – Get Rating) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 2,890,000 shares, a growth of 30.8% from the May 15th total of 2,210,000 shares. Based on an average daily trading volume, of 455,200 shares, the days-to-cover ratio […] ....

Barclays Plc , Eton Pharmaceuticals Inc , Surface Ophthalmics Inc , Pharmaceuticals Inc , Institutional Investors Weigh In On Harrow Health , Mendota Financial Group , Harrow Health Company Profile , Harrow Health Stock Down , News Ratings For Harrow Health Daily , Jump Financial , Marshall Wace , Harrow Health Inc , Harrow Health , Get Rating , Financial Group , Health Stock Down , Street Capital , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Harrow Health Daily ,